BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu S, Du L, Xu D, Lu Z, Xu T, Li J, Xu K, Ye J, Song Y. Ascitic fluid total protein, a useful marker in non-portal hypertensive ascites. J Gastroenterol Hepatol 2020;35:271-7. [PMID: 31247673 DOI: 10.1111/jgh.14768] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Du L, Wang D, Wei X, Liu C, Xiao Z, Qian W, Song Y, Hou X. MS275 as Class I HDAC inhibitor displayed therapeutic potential on malignant ascites by iTRAQ-based quantitative proteomic analysis. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02101-7] [Reference Citation Analysis]
2 Guo YY, Peng XL, Zhan N, Tian S, Li J, Dong WG. Development and validation a simple model for identify malignant ascites. Int J Med Sci 2021;18:1966-74. [PMID: 33850466 DOI: 10.7150/ijms.53743] [Reference Citation Analysis]
3 Xia RQ, Yuan W, Ye MS, Wang J, Zeng XQ, Chen SY. Recurrent ascites in a man with liver cirrhosis: A case report. J Dig Dis 2021;22:727-30. [PMID: 34783434 DOI: 10.1111/1751-2980.13067] [Reference Citation Analysis]